AI assistant
Neurogene Inc. — Director's Dealing 2015
Aug 10, 2015
33497_dirs_2015-08-10_3cd9333c-bae8-4540-8f34-5cf7cdcf89b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2015-08-07
Reporting Person: BAKER BROS. ADVISORS LP (10% Owner)
Reporting Person: Baker Bros. Advisors (GP) LLC (10% Owner)
Reporting Person: BAKER JULIAN (10% Owner)
Reporting Person: BAKER FELIX (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2260 | Direct |
| Common Stock | 2260 | Direct |
Footnotes
F1: Common shares held directly by Felix J. Baker and for which Felix J. Baker has sole beneficial ownership. These shares were received in an in kind pro rata distribution from an affiliated investment fund in January 2015 without consideration. This form 3 has been amended to reflect these shares inadvertently omitted from the previous filing.
F2: Common shares held directly by Julian C. Baker and for which Julian C. Baker has sole beneficial ownership. These shares were received in an in kind pro rata distribution from an affiliated investment fund in January 2015 without consideration. This form 3 has been amended to reflect these shares inadvertently omitted from the previous filing.